Institute of Pathology, University of Bern, Bern, Switzerland.
J Neuropathol Exp Neurol. 2023 Feb 21;82(3):221-230. doi: 10.1093/jnen/nlac131.
Machine learning (ML), an application of artificial intelligence, is currently transforming the analysis of biomedical data and specifically of biomedical images including histopathology. The promises of this technology contrast, however, with its currently limited application in routine clinical practice. This discrepancy is in part due to the extent of informatics expertise typically required for implementation of ML. Therefore, we assessed the suitability of 2 publicly accessible code-free ML platforms (Microsoft Custom Vision and Google AutoML), for classification of histopathological images of diagnostic central nervous system tissue samples. When trained with typically 100 to more than 1000 images, both systems were able to perform nontrivial classifications (glioma vs brain metastasis; astrocytoma vs astrocytosis, prediction of 1p/19q co-deletion in IDH-mutant tumors) based on hematoxylin and eosin-stained images with high accuracy (from ∼80% to nearly 100%). External validation of the predicted accuracy and negative control experiments were found to be crucial for verification of the accuracy predicted by the algorithms. Furthermore, we propose a possible diagnostic workflow for pathologists to implement classification of histopathological images based on code-free machine platforms.
机器学习(ML)是人工智能的一个应用领域,目前正在改变生物医学数据的分析,特别是包括组织病理学在内的生物医学图像分析。然而,该技术的应用前景与它在常规临床实践中的有限应用形成了鲜明对比。这种差异部分归因于实施 ML 通常所需的信息学专业知识的程度。因此,我们评估了 2 个可公开访问的无代码 ML 平台(Microsoft Custom Vision 和 Google AutoML)用于对诊断中枢神经系统组织样本的组织病理学图像进行分类的适用性。当使用通常 100 到 1000 多张图像进行训练时,这两个系统都能够基于苏木精和伊红染色图像进行高精度(从约 80%到近 100%)的非平凡分类(胶质瘤与脑转移;星形细胞瘤与星形胶质细胞增生,预测 IDH 突变肿瘤中的 1p/19q 共缺失)。发现对预测准确性的外部验证和阴性对照实验对于验证算法预测的准确性至关重要。此外,我们提出了一种可能的诊断工作流程,供病理学家实施基于无代码机器平台的组织病理学图像分类。